SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

CytomX Therapeutics, Inc. CTMX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Analyst Price Target

CytomX Therapeutics, Inc. (CTMX) 有 7 个已识别的同行可供比较在 Healthcare 板块. 同行包括 ACHL, ASMB, NLTX, NUVB, NXTC, SPRO 等.

CTMX 的市值为 $776.34M, 而同行平均市值为 $351.12M. CTMX 显著大于其平均同行.

同行与相似公司 — CTMX

Achilles Therapeutics plc

$1.48 +0.68% $60.83M

Assembly Biosciences, Inc.

$29.81 +1.26% $472.87M

Neoleukin Therapeutics, Inc.

$3.49 +1.45% $8.2M

Nuvation Bio Inc.

$4.82 -0.72% $1.67B

$12.02 -5.87% $32.21M

Spero Therapeutics, Inc.

$2.64 -5.04% $152.83M

Instil Bio, Inc.

$8.89 +5.33% $60.29M

其他人也在看

Nuvation Bio Inc.

Assembly Biosciences, Inc.

Spero Therapeutics, Inc.

Achilles Therapeutics plc

Instil Bio, Inc.

Neoleukin Therapeutics, Inc.

Eli Lilly and Company

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言